Zantac Lawsuit


Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist

Friday, July 10, 2015

Seroxat Withdrawal Diary (Guest Post)






I do love it when people contact me with their Seroxat stories. Although they are harrowing to read I do feel somewhat privileged to spread these accounts via my blog, if only to warn others and/or offer guidance to those who are suffering Seroxat addiction.

This guest poster wishes to remain anonymous, his story is familiar. His story is a classic example of what is not being done to help people suffering Seroxat addiction.

I don't necessarily agree with some of the methods used by Anonymous but he did what he had to do because, as I have said many times, there is no help whatsoever for people who have become hooked on Seroxat.

The British drug regulator, the MHRA, read accounts like this all the time. They sit in their ivory towers, shrug their shoulders and continue to ignore the Seroxat withdrawal problem. GSK don't wish to help those suffering either, by doing so they would have to admit there was a problem with withdrawal - and if they admitted there was a problem they would pretty much lose any withdrawal cases against them through the courts.

I think that when anyone forms associations with GSK, be they Channel 5, Jenson Button or Dame Kelly Holmes, they should all sit down and read stories like the one you are about to read, it's just one of many hundreds - others can be found here, here and here. 

People or companies in privileged positions should be speaking out against GSK and not supporting them.

Upon reading them maybe then, the aforementioned, should head on over to YouTube to play the song GSK chose to play to their reps at various Seroxat presentations in the US. (Here) - There's an alternative version of the song here.

Bob Fiddaman.




"If ‘discontinuation reactions’ occur in patients stopping [Seroxat], the majority will experience symptoms that are mild to moderate in intensity, and are usually limited to two weeks."
Mary Anne Rhyne, GlaxoSmithKline spokesperson - 2005



Seroxat Withdrawal Diary

I was prescribed 20mg Seroxat at aged 17 (Feb 1998), my Dr diagnosed depressive symptoms following major knee surgery ( I snapped my cruciate ligaments playing football), I went from being extremely sporty and fit to being unable to play football or any other sports for years to come. I have no recollection of life pre Seroxat as I was only 17 I do not know if my personality now is as a result of the drug or whether or not it will change when I come off of it.

I attempted to withdraw from the drug at least three times over the years in the 2000’s however this was done as a take one tablet one day, then miss a day routine which has since been recognised as ineffective.  My attempts to withdraw from the drug only every lasted a week at most  as I would become almost suicidal and suffer extreme physical withdrawal, fainting feeling’s sapping feelings, nausea and extreme flu like symptoms I would also became aggressive and emotional.

There never appeared to be a good time to attempt to come off this drug for a prolonged period as I was at university then full time employment, now 17 years later I have developed endocrine problems which to be fair I may have had all along  and may always have been as a result of Seroxat, I believe it can have an effect on prolactin levels which in turn cancels out testosterone and causes erectile dysfunction and loss of libido, I now attend an endocrinologist for this and receive a depot injection of nebido (testosterone) every three months, historically I was prescribed Viagra over the years also but this ceased about 7 years ago due to NHS criteria changes for prescribing the drug.

On 08/08/14 my first child was born, and that along with other reasons prompted me to seriously get off Seroxat as I was more educated and aware that there was now a liquid tapering method which can be successful.

Here is my withdrawal account for the last six months attended G.P in Jan feeling terrible and dose increased to 30mg, spoke to my endocrinologist 3 days later and discovered the medicine may be causing some of my problems. I attended my G.P again who agreed on reduction of Seroxat / withdrawal.

06.01.15 approx. - prescribed liquid paroxetine and was on 15ml to start (30mg), tapered down 1ml per week to 10ml (20mg) by 14.02.15) during this time experienced anxiety, mood swings stomach cramps, faecal incontinence due to irritable bowel) - prescribed quetiapine 25mg to assist with anxiety, could not tolerate it and so stopped after a few doses.

It was becoming more difficult for me and so I was referred to a psychiatrist and cpn to help with the withdrawal stage from 20mg (10ml) was prescribed trazadone 50mg to help with anxiety again made me too drowsy and made my body ache so only too a few doses.

Agreed on a 1ml every two weeks tapering regime with psychiatrist, was prescribed buscopan for stomach cramps and mebrevine for irritable bowel / incontinence.

14.02.15 - 10ml (20mg)
28.02.15 - 9ml (18mg)
14.03.15 - 8ml (16mg)
28.03.15 - 7ml (14mg)
11.04.15 - 6ml (12mg)
25.04.15 - 5ml (10mg)
09.05.15 - 4ml (8mg)
23.05.15 - 3ml (6mg)

My physical symptoms got significantly worse throughout this period and on top of this the frequency of my mental health symptoms increased from irritability a few times per week too 24/7  extreme mood swings agitation, crying uncontrollably, insomnia, out of body feelings and feeling like I was going to die.

Around the 3ml point I was prescribed 2mg diazepam to help with this, they were not effective and this was increased to 10mg daily of diazepam, I was also taking 30/5000mg of co co-codamol up to 8 times per day for migraines i was suffering.

After prolonged discussions and by taking advice from the protocol by Dr David Healy it was agreed that I would move to a halve and halve approach, i.e take halve your dose of Seroxat ie 1.5ml and the equivalent dose of Prozac - 0.80ml think thinking being the longer half life of Prozac will help with withdrawals and I should stay on this dose of Prozac whilst completing my withdrawal from Seroxat I have now been taking the following regime which I started yesterday -

(As an aside I was warned that there was the possibility of serotonin syndrome with this approach which can cause all the symptoms I am currently having as well as convulsions fever and ultimately death, I was also warned that taking 2 x SSRIs simultaneously had a magnifying effect which could cause heart problems and so I am booked in for an ECG today. I was also warned to expect increased irritability during the first week of taking Prozac, so may need to continue taking 10mg of diazepam daily, im now worried about withdrawal from this and the codeine I have been taking.)

01/06/15 - 1.5ml (3mg) Seroxat & 0.80ml 3mg approx of Prozac
08/06/15 - 1ml (2mg) Seroxat & 0.80ml 3mg approx of Prozac
15/06/15 - 0.5ml (1mg) Seroxat & 0.80ml 3mg approx of Prozac
22/06/15 - 0 Seroxat & 0.80ml 3mg approx of Prozac

If I make it too that point my plan is too come off Prozac as follows,  I have been told I can do It rapidly given its longer half life

23/06/15 - 0.60ml of Prozac
24/06/15 - 0.40ml of Prozac
25/06/15 - 0.20ml of Prozac
26/06/15 - finished

I then plan to see how I react as the Prozac should theoretically be out my system by 02/07/15 and I want to recover for a few weeks before returning to work to ensure I am physically and mentally well enough.

I realise this most recent plan may not work but this is my care plan agreed with my psychiatrist.


Update 21/06/15

The last three weeks have been extremely difficult but the use of halve Prozac and a tapering dose of 0.5ml Seroxat every week as advised by Dr Healy has to an extent been successful. I doubt I would have managed to do it without using this method and if I had been given the option six months ago when I first met with my G.P /Psychiatrist I would have used this method right from the start.

Essentially I reduced from 3mg or 6ml of Seroxat onto start on  01/06/15 - 1.5ml (3mg) Seroxat & 0.80ml 3mg approx of Prozac. I stuck to the plan above and reduced the Seroxat by 0.5ml or 1mg (weekly) whilst maintaining the 0.80 or 3mg dose of Prozac throughout. I administered my last 0.5ml dose of Seroxat today along with my maintenance dose of Prozac 0.80ml and as far as I am concerned that is the last time I will ever take Seroxat.

I plan to reduce the Prozac by 0.20ml increments over the course of four days starting tomorrow and by that point be SSRI free aside from the residue SSRI chemicals that remain in my system and store in my fat cells.

The last 21 days have been very difficult both mentally and physically and I have been monitored weekly by my CPN. All the before mentioned physical symptoms have became worse with more frequent diarrhoea, the aggression has reduced but this has been replaced by 24/7 anxiety, panic attacks, complete and utter distress, palpitations, sweating etc, this is the symptom I find most difficult to deal with ( I feel like im going into an exam magnified by 1000x or have just had a near car crash) I realise it is my body's fight or flight system kicking in but it is constant and for no good reason apart from withdrawals. I have had to suffer these symptoms during the day however I have joined a gym which I now attend 3 times per week in an attempt to reduce the extreme adrenaline / anxiety feeling, boost my mood and also try to destroy the reaming Seroxat living in my fat cells. The Gym has helped slightly during the day but at night my mind is thinking about three different subjects at once and I am in a constant state of panic. I have been prescribed 10mg diazepam which I have been taking nightly for the last 21 days to enable me to shut down and sleep.


"The other symptom which has continued but increased in its severity is the feeling of unreality." 


I have also been having very vivid dreams which ultimately are negative in nature and terrifying , for some reason they are mostly set around when I was 17 and commenced Seroxat, I feel my memories may be regressing to when I started it now that I am almost off it. I have continued to have emotions swinging wildly however the aggression is no longer present.

I continue to have Headache’s however I have reduced my use of co-codamol 30/500 from 8 per day to 2-4 per day. As mentioned I have had terrible Nausea (feeling like I have just woke up from a general anaesthetic ( I know this feeling as I have had 7 major operations) , Diarrhea which is very acidic (bile salts) and has led to me needing to use baby wipes, nappy sacks and bepanthan to prevent a breakdown of my skin integrity, not only is this painful but it is extremely degrading and embarrassing for a 35 year old man.

The other symptom which has continued but increased in its severity is the feeling of unreality, an example of this is when I walk around a supermarket in a dream like state oblivious to everyone around me, I feel like I have a haze over my eyes and the immediate world around me is not real for periods of time, I know there is a clinical term for this but I am unsure what it is.

Overall I feel rundown and exhausted, I am very anxious about being free of Seroxat after 18 years and worry about the symptoms persisting and for how long they will persist, as I am due to return to work in in one weeks time on a phased return. I am also concerned about coming off the diazepam now and I will need to discuss a tapering regime for this with my psychiatrist also.

Mentally I feel very alert (super alert due to the anxiety) so I would not say I was depressed or showing any need for future antidepressants, at this point in time and continue to believe that I do not have clinical depression and actually I strongly believe I never did and was miss diagnosed / prescribed this evil medication. I continue to have a lot of anger towards Glaxo Smith Kline and I will pursue legal action as far as I can against them.

As an aside I spent time tonight disposing of all my antidepressant tablets , I had boxes of them in a drawer which I did not want to be reminded of. I felt this was a useful exercise, and gave me some closure on what has been a very long journey.

I will update again in the coming week’s if and when I come off my remaining dose of Prozac on how I feel post Seroxat and Prozac back in the real world and at work after a six month absence.

Update 22/06/15

I have felt severely ill all day agitation and aggression is back, I smashed my laptop earlier today over a petty incident and spent the next three hours sobbing in remorse £75 mistake!. I have developed severe flu like symptoms and have a fever, I am due to meet my CPN tomorrow to discuss how I will cope throughout the next week.

Update 25/06/155

A week before my last dose of Seroxat I felt a dental abscess developing on a historical crown / bridge don 8 years+ ago. I went to the dentist’s and was prescribed a 5 day course of amoxycillin 150mg per day despite the leaflet that comes stating dental abscesses should be treated with a dose of 3g daily, I called back and questioned this but got no where. Finished the course around the time of my fever developing 22/06/15 temp between 37 – 39 degrees and only reducing with paracetamol, gum and tooth still sore so back to regular dentist who prescribed me metranidazol antibiotics 3 per day which I am due to finish tomorrow. However on top of that I developed a wheeze, I have asthma and a severe sore throat cough so I felt the infection had spread, seen an out of hours G.P at hospital after initially being fobbed off by NHS 24 and was diagnosed with upper respiratory tract infection and given yet another course of antibiotics, this time clarythromicin 7 day course 2 per day, these ones seem to be working but I need to take them on top of the last dental ones and I'm feeling sick and have a metallic taste.

The upshot of all of this going on is I am physically exhausted and so have no adrenaline problems at present, I do however feel very nauseous, can’t know if this is withdrawal or reaction to infection / antibiotics.

I spoke to my Psychiatrist today about how to manage any symptoms of anxiety should they return when I am in my work place. I asked about beta blockers as an alternative to diazepam and she agreed this was a good suggestion and licensed for anxiety but ruled it out due to the contraindications with asthma. Instead we have agreed that I will take a 5mg diazepam in the morning if anxious and a 5 at night and also add in zopiclone a sleeping tablet if I feel the 5mg diazepam does not put me too sleep.

I was also at the dentist today who took an x-ray and confirmed I will require root canal treatment over the coming months and also a surgical procedure in my upper jaw bone as the infection is has spread to my bone and so my gum has to be slit and a hole drilled in the bone to treat the infected area, this will all be done over the coming months in a dental hospital. He explained that I must be very run down for internal root infection which on a sealed tooth of over 8 years to trigger infection, it has been internal not external, i.e no cavity just bugs taking a chance to grow as my immune system is so low at present, I feel this is as a result of the last six months withdrawal.

Due to infection there has been no gym this week which I am disappointed about but hope to return 3 x times weekly asap.

I took my last dose of Prozac also this morning approx. 0.20ml again don’t know how im reacting to that with everything else going on. On the positive side the anxiety has massively reduced since infection started and I have slept the last 2 nights without the need of diazepam.

I return to work on Monday 29/06/15 for a half day on a phased return so hope I am physically well enough to get out my bed and go otherwise I am going down to half pay. I have a full 8 week phased return to work after a six month absence organised, I’ve had to use accrued P/Hs and A/L for this which will leave me with no holiday’s for 4  months however I have accepted this and my manager has been very understanding and accommodating.

I am now officially SSRI free apart from the Prozac half life and Seroxat deposits in my fatty tissue cells, I aim to get rid of the latter by hammering the gym to destroy historical fat, only good things can from this. I have been T-total since Jan and I now avoid caffeine and drink plenty of water. I'm taking multi vitamins and eating well. I still have the diazepam and co-codamol issues to deal with but im sure I will just taper off them slowly as I get better. Only time will tell how I will deal with being SSRI free after 18 years but im positive that I have beat this drug addiction and hope to never take anything like it again, I truly believe I will be a stronger healthier person at the end of this journey and despite it being six months of hell it has been worth it.

Update 01/07/15

Still feeling a lot of anger towards GSK and I am being consumed with a need to seek justice for six months of physical and mental torture, and I am finding it difficult to understand why something is not bee done about this legally and by the NHS. I feel as though I am now going through a process similar to that of grieving, i.e anger, sadness etc, unfortunately I am stuck it seems at the anger stage. Physically I do still have a lot of anxiety and a racing mind, however I do not feel depressed (the whole basis of prescribing the drug in the first instance!). My physical symptoms have settled down and my chronic diarrhea has also settled down. I have attended a half day at work and coped fine and have another half day tomorrow.

I had root canal surgery yesterday and the dentist explained to me that filling which was inserted 8 years ago was done poorly and as a result it came out as a large black sludge of infection, which in turn has traveled to my Jaw bone and has been systemically poisoning me for the last 8 years and will continue to do so until I get the affected bone operated on and removed. So again it is difficult to tell physically whether I am feeling ill due to withdrawal or dental infection, another case of medical negligence, which has not been picked up until now despite numerous x rays of my mouth.

I am now taking extra strength omega, three 15ml per day which contains very high levels of EPA DHA, (seven seas extra high strength = 2300mg of EPA &DPA per 10ml) as a comparison most 100mg omega capsules contain approx 200 – 300mg of EPA & DPA so you would need to take 8-10 capsules instead of 2 x 5ml spoonful’s to get a dose effective enough to repair brain cell function, these chemicals are known to repair brain function as well as your immune system and a whole host of other things I can find no negative trials on this only positive ones.

I continue to take 10mg of diazepam to make me sleep, I tried the prescribed sleeping tablet but I woke very quickly after taking it as my mind was still racing, I have only stopped taking Seroxat about 10 days ago after taking it daily for almost 18 years! I also stopped taking Prozac approx 5 days ago so again due to its half life this should now be out of my system.

Update 5/07/15

For the last three days I have felt happiness and calmness that I have not felt for over six months, I am still slightly agitated and find it difficult to unwind at nigh time so continue to need 10mg of diazepam nightly to get to sleep, the sleeping pills are not effective for my particular needs. My aim is too stay on the diazepam during my phased return to work (next 7 weeks) and then see if I'm coping with being back at work full time before attempting a phased withdrawal from this drug also. My 30/500 co-codamol intake has also reduced from 8 per day to 2-4 per day max.

09/07/15 

Most of my physical withdrawal or discontinuation symptoms have ceased, my bowel movements are normal and regular and I have much less headaches. I do still feel a bit anxious but no where near as much as I did during withdrawal and I feel this is improving every day. The sleeping tablets were not suitable for me a woke very quickly after taking them and even with 5mg of diazepam I only slept for a few hours. I continue to take 10mg of diazepam nightly and 15ml of cod liver oil daily. I have agreed with my psychiatrist that I will remain on a weekly dispense regime of 10mg nightly until I am back at work full time this will be another six weeks as I am now 2 weeks into my phased return to work, I have complete 4 half days over two weeks without issue, my first full day is tomorrow. I then intend to withdraw from the diazepam at a rate of 2.5 mg per week over the coming weeks and I am looking into Pal McKenna’s sleep hypnosis cd/ mp3 as an alternative as I feel a lot of my issues sleeping is to do with post-traumatic stress from discontinuation syndrome and a severe assault I suffered 2 years ago. Hopefully my limited use of co-codamol will also reduce further over this this period also however post-surgery pain from upcoming dental surgery my put a spanner in the works there.

One really interesting ting came out of today’s meeting with my psychiatrist, I explained to her I had purchased a gadget called a Microsoft band which is a smart watch / exercises band but also measures sleep very accurately. It clearly shows that I am having very poor sleep at night waking on average 9 times per night and I am having very little quality sleep (REM sleep) mostly light sleep, the diazepam and withdrawal may be to blame for this as when I wake in the morning following a bad night’s sleep and I then go back to sleep for a power nap It is mostly REM sleep, in fact yesterday I had more REM sleep in a power nap of 2hrs than I did the night before during a 7.5 hr sleep.

My psychiatrist asked me if it tracked my resting pulse which it does and this is the bit I found really interesting. When I was at the height of my discontinuation syndrome distress I was sent for an ECG to monitor the risk of serotonin SSRI’s Seroxat and Prozac simultaneously, my heart beat at that point showed as 120 beats per minutes, very fast for a resting heart in fact classed as (tachycardic) however post withdrawal, or at least over the last week I have owned the band my heart beat has been between 70 and 80 – normal, this could probably not be used in a court of law but to me it does show a  physiological correlation between discontinuation syndrome and an increased heart rate probably associated with anxiety etc.

I have spoke to my GP and gave him a copy of this medical account for my G.P notes should the case every come to court and have requested that he completes a yellow card warning for me in relation to Seroxat after reading them, which he has agreed to do.

Overall I am feeling better by the day, I'm almost certain now that I do not have and have never had any underlying mental health condition and I am glad I came off the drug despite how hard it has been.

I will see my psychiatrist again in approx 12 weeks when I should be off the diazepam and continue to see my CPN fortnightly or as required.

Rational for my anger and mistrust

In the last 10+ years Panorama ran four different documentaries on the scandal involving this drug. There is evidence of (bribery), deliberately hiding negative medical evidence during trials in order to get the drug licensed and prescribed and denying any responsibility for a drug which they have created knowing it has severe side effects when attempting to withdraw from it as well as causing birth defects and unfortunately in the US it has been deemed to be responsible for suicide’s and homicides.

In the US GlaxoSmithKline have settled out of court with those unfortunate enough to have been prescribed this drug with the caveat of gagging orders so further legal action cannot be taken in countries such as ours , however to date not one penny in compensation has been paid to British victims of a drug which is their best seller I believe and also the most widely reported drug for side effects to the MHRA (medical regulatory body in Britain) above drugs such as diazepam etc.

I will personally seek legal advice on taking this matter moving forward, given that it is public record that GSK deliberately hid negative withdrawal clinical trial information from the regulatory bodies and I was also prescribed as a minor off licence again this has been banned since 2003. I will also perhaps start lobbying MSPs to take up this matter as I have read hundreds of cases similar to mine on the Seroxat users group and through the blog of Bob Fiddaman, we cannot continue to be dulled down and forgotten about with more pills from the physicians and pharmaceutical companies that created and prescribed this monster in the first place.

Further research has highlighted how deep rooted and endemically corrupt this situation is, as a starter the current CEO of the MHRA (the people who are supposed to protect NHS patients from faulty drugs is a Dr Ian Hudson, who coincidentally used to be the World Safety Officer for SmithKline Beecham (now GlaxoSmithKline), what hope do we have of justice when this is the situation we are faced with?

My feeling towards prescribers of mental health medication G.Ps and psychiatrists is that they inherently want to stabilise what they see as poor mental health and have very little knowledge when it comes to dealing with making your symptoms worse to make you better, i.e dealing with withdrawal from SSRIs in the correct manner.

They need to understand that there will be a large proportion of the population who for whatever reason were misdiagnosed and put on these drugs without having clinical depression either due to naive incompetence or more worryingly due to bribery and propaganda from pharmaceutical companies on GP’s, (evidence of this in Bob Fiddaman’s blog) or have recovered from reactionary depression but discontinuation symptoms are makings physicians think they are still depressed. This drug has been designed to mimic the symptoms of mental illness when withdrawing and so unless you have knowledge / conviction and the determination to be drug free, then the millions of patients in Britain who are on this drug will be caught up in the perpetual cycle of either continuing to take the drug (ideal situation for GSK financially and massive drain on NHS resources ) or be put onto alternative mental health medication as psychiatrists do not have the skill base to differentiate between withdrawal and actual mental illness.

My hope is that all G.Ps and psychiatrists start to recognise the real problem that is “discontinuation syndrome” from certain SSRI medications and that they use Dr Healys protocol or even better develop their own to challenge this problem instead of just resorting to swapping for another antidepressant which is the easy option for them. The drugs companies like GSK are having their cake and eating it due to this perceptual cycle of drug prescribing and I would not be surprised if this was their intention all along given the profits involved.

References 
http://fiddaman.blogspot.co.uk see all 4 Panorama episodes about Seroxat on here
http://wp.rxisk.org/antidepressant-withdrawal-vs-story/ - read the 86 comments / accounts
http://www.Seroxatusergroup.org.uk/articles.htm
https://truthman30.wordpress.com/












Thursday, July 09, 2015

The Seroxat/Paxil Yugoslavia Trial Part II






Following on from Part I.

In summary, In 1988 GSK, then SmithKline Beecham (SKB) sponsored clinical trials in Yugoslavia. The purpose of the trials was to show how Paxil (known as Seroxat in the UK) could, when stopped, cause a relapse in depression. SKB never took into account that those relapsing (after stopping Paxil) could have been suffering withdrawal symptoms.

With the results they wanted, SKB then provided the FDA with apparent evidence that showed patients staying on Paxil continued to enjoy a normal, "depression free" life, but that those abandoning the drug would suffer relapse back into a depressive state.

One thing that was irksome to SKB was that they had to convince the FDA that the relapses shown in the study were not simply patients suffering withdrawal.

Enter Dr. Thomas Laughren of the FDA.

This from the legal brief.

SKB decided to massage the problem through back channel communications with Thomas Laughren, MD, a high official in the FDA.SKB felt if they could convince Dr. Laughren of the good "relapse" statistics in the Yugoslavia trial, they could avert the hard questioning of the FDA committee members on the withdrawal issue.Having "FDA" on your side before the FDA committee, it was felt, was good politics and a way to subtly shift responsibility for the issue away from SKB. To implement their tactic, SKB emphasized to Dr. Laughren that the Yugoslavia trial protocol was designed to detect relapse.At the same time, SKB told Laughren, they would do their best to detect and report on Paxil's withdrawal issues during Phase II. Given that "withdrawal" at that moment was not a front burner issue, that explanation satisfied the FDA official. 

On October 5, 1992, the FDA's Psychopharmacologic Drugs Advisory Committee voted unanimously that Paxil be recommended for approval for the treatment of depression.

FDA Neuropharmacological Drug Products Division Director Paul Leber, MD, opened the meeting by stating: "The division's clinical review team and its statistical consultants have concluded that the evidence submitted in SmithKline Beecham's NDA for paroxetine convincingly documents that paroxetine...is both a safe and effective antidepressant." 

SKB had shown that the 172-patient, 52-week Yugoslavian study of paroxetine for prevention of depression relapse showed "a highly significant difference" between drug and placebo, they showed that in that trial, 15% of Paxil-treated patients relapsed in a year, with an average time to relapse of 30 months, while 39% of placebo patients relapsed in an average of 17 weeks after the study began.

SKB had finally got their foot on the bottom rung of the antidepressant ladder, it had taken longer than usual because around the time another antidepressant, Prozac, was making news.

Here's the legal brief again...

There had been press reports that Prozac, originally appearing on the market in 1988, had caused many suicides.FDA was thus compelled to review Prozac and--obviously--considered it in their own interest to tread softly before approving additional SSRI's for the market.Condemning Prozac and acknowledging the suicide issue, however, would suggest in many quarters that FDA was to blame for allowing a dangerous drug on the market in the first place. Few bureaucracies admit they are wrong, and all have a tendency to herald the status quo.Thus while assuring Congress and the media that they would thoroughly investigate the recent Prozac allegations, the FDA was actually in cahoots with the SSRI manufacturers on the suicide issue. On October 3, 1990, an FDA official, the Director of Neuropharmacological Drug Products, telephoned SKB headquarters. He asked to speak to SKB's Regulatory Affairs director, a Ph.D. The call was made at a location that could not be traced back to the FDA official's office. This person making the call was the senior FDA official responsible for Paxil's application. The official made clear to SKB his purpose. It was not to "lay down the law" and ensure SSRI testing was refined. It was to tell SKB how to get around the suicide problem for Paxil's upcoming application--and further not to worry.

By the way, the "legal brief" I am referring to is the entire formal complaint brought against SmithKline Beecham that was filed in California on August 19, 2000. (Nguyen & Farber, plaintiffs vs. SmithKline Beecham Corporation) - The full brief is publicly available and makes very interesting reading. You can download it here.

When the FDA committee convened on October 5, 1992 there were 6 panel judges who would decide whether or not Paxil would be 'good to go'.

Dr. Laughren told the panel, "There was no systematic effort really to look at the withdrawal syndrome, but in looking at the patients coming off of...(Paxil)...in the clinical trials, there was no strong suggestion of a withdrawal syndrome."

Do you, like me, find this statement utterly bizarre?

If there was no efforts made to look at withdrawal then how did he, or SKB for that matter, arrive at, "...there was no strong suggestion of a withdrawal syndrome?"

When SKB addressed the panel they pulled out all the stops.

Here's the legal brief...

SKB boldly went to the next level.SKB asserted to the committee that SKB had studied "whether or not there is a discontinuation syndrome in patients who are abruptly discontinued from Paxil."The SKB representative continued:"To end with a brief discussion of whether or not there is a clear withdrawal syndrome, we have pulled upon the ...(Yugoslavia trial)..."Then, SKB made an outrageous and categorical falsehood. The SKB representative told the committee SKB in the Yugoslavia trial attempted to "systematically assess a discontinuation syndrome."This statement was in direct contradiction of Dr. Laughren's earlier statement in the day that "There was no systematic effort really to look at the withdrawal syndrome."Having refuted the FDA representation that there were no "systematic" tests on Paxil withdrawal, SKB then further claimed the tests were successful in that regard.The SKB representative told the committee they examined the data on the Phase II placebo group and that "few numbers of patients experienced any adverse event after being randomized off...(Paxil)...into the placebo group and the percentages are certainly very small."What SKB failed to add was that no "adverse events" were reported on the placebo group because the eighteen (18) placebo victims' symptoms were reported by SKB to have been "relapse" symptoms.
Dr. Laughren, on hearing SKB contradict his earlier statement,

The legal brief...

Dr. Laughren interrupted the SKB speaker.From his perspective sitting in the audience, Dr. Laughren understood there were "crossed signals" before the committee between the FDA staff and SKB, and that the discrepancy required immediate correction.Dr. Laughren additionally understood there was now a gap in the testimony.Dr. Laughren understood the placebo group's statistics meant nothing without comparison to the Paxil group. He then yelled up to the podium to the SKB representative, and the following exchange occurred:

Laughren:"Unfortunately you did not contrast...(the placebo group)...with the rates...(of adverse experiences)...in the patients who continued on...(Paxil)..."
SKB:"Right. I know the point you are going to raise, that it really does not look that different..."
Laughren:"That was my impression."
SKB:"...from what you saw in the...(Paxil)...group, and that is a well founded point. So we very much agree with your earlier conclusion that there is no clear withdrawal syndrome but this was our attempt to try and investigate it in somewhat of a controlled fashion."

In effect, SKB had just pulled off a coup. SKB had successfully and deceitfully maneuvered Dr. Laughren into making the case before the committee that withdrawal tests were conducted, and they proved Paxil "clean" on the withdrawal issue. SKB got Dr. Laughren to do their heavy lifting before the committee on a subject the FDA official had no personal knowledge of. SKB simply stepped aside and put icing on the cake with a polite "we very much agree with...(Dr. Laughren's)...earlier conclusion that there is no clear...(Paxil)...withdrawal syndrome."

SKB's tactic to skirt the withdrawal issue at the committee hearing was thus successful.After representation to them that Paxil had been systematically tested for withdrawal and that the tests were successful, the committee voted to approve Paxil. 

The legal brief, as I mentioned earlier, was filed some years after the above FDA meeting. In Nguyen & Farber, plaintiffs vs. SmithKline Beecham Corporation, plaintiffs filed suit against GSK because they had suffered serious adverse withdrawal reactions when trying to stop Paxil. The case was resolved and over 3,000 plaintiffs received undisclosed compensation. They also had to sign confidentiality agreements that, in essence, laid no blame on Paxil or SKB.



2015 UK Seroxat litigation.

Almost 9 years ago a group action was filed against GlaxoSmithKline by UK patients who alleged pretty much the same as the 3,000 or so in the Nguyen & Farber, plaintiffs vs. SmithKline Beecham Corporation case.

No effort has been made by GlaxoSmithKline to resolve the UK litigation. At the time of filing a GSK spokesperson said, "We believe there is no merit in this litigation. Seroxat has benefited millions of people worldwide who have suffered from depression.''

Meantime, the UK group action continues in its fight to seek damages for those British patients who, just like American patients, suffered severe withdrawal at the hands of Seroxat.

If the difference between judicial law in America and the UK show one thing in this case, it's timescales. Nguyen & Farber, plaintiffs vs. SmithKline Beecham Corporation was filed in 2000 and resolved in 2002. The UK litigation was filed in 2008 and GlaxoSmithKline, it appears, remain unconvinced that they have a case to answer.


More on the UK Seroxat litigation at a later date.



Bob Fiddaman.




Wednesday, July 08, 2015

The Seroxat/Paxil Yugoslavia Trial Part I







Very little is known publicly about the Yugoslavia paroxetine (Seroxat UK, Paxil US) trial. What is public, makes very interesting reading. Interesting because it covers the subject of withdrawal, something which GSK have denied for years is a problem with their antidepressant.

I'm going to try and break this down so it's easily digestible. The information was taken from a Paxil lawsuit that was filed in California on August 19, 2000. (Nguyen & Farber, plaintiffs vs. SmithKline Beecham Corporation) GSK resolved the suit in January 2002.  The results of the resolution, including any settlement by GlaxoSmithKline, were never announced.

The legal brief for the lawsuit is a very interesting document, in as much that it mentions clinical trials carried out in Yugoslavia (as the country was known then)

During this time GlaxoSmithKline were known as SmithKline Beecham (SKB)

According the the legal brief, here's what happened...

In 1988, a clinical trial in Yugoslavia commenced. The trial was sponsored by SKB and could have (should have) been an ideal opportunity for SKB to address the withdrawal issue. The trial was known as the "Yugoslavia trial" or "relapse trial."

At this time, SKB were seeking approval of Paxil and the Yugoslavia trial was to show the FDA (the US drug regulator) how effective Paxil was in treating depression - they would also try to show the FDA how it was important to keep taking Paxil and not to stop... because if you did stop then you would go into relapse, in other words, SKB were trying to prove that stopping Paxil meant the patient's original illness would return.

Here's how they achieved this...

First off, participants in the clinical trial had to have suffered a major depressive disorder and experienced a history of recurring depression.

In "Phase I" of the trial ALL patients were given Paxil. "Phase II," of the trial saw those same patients split into two groups. One group (Group A) remained on Paxil while the second group (Group B) shifted to placebo, a sugar coated pill.

Those in Group B would have, in essence, been going through a cold turkey withdrawal of Paxil - something that GSK have clearly stated that no patient should do when coming off Paxil. For the purposes of this particular clinical trial, however, it appears that they wanted patients to suffer withdrawal symptoms so they could present the FDA with evidence that Group B were suffering a relapse of their original illness - ergo, the illness had returned once they had stopped taking Paxil. In actual fact (my opinion and the opinion of many others) SKB were suggesting that those experiencing withdrawal issues were actually experiencing a return of the original depressive symptoms. Win-Win for SKB.

It was SKB's intention to show the FDA that Paxil patients do not "relapse." So, it appears they masked the results. From a business point of view I can understand this. Understand but not agree with.

Shortly after Phase II of the trial commenced it is alleged that the placebo group (Group B) began experiencing massive Paxil withdrawal symptoms. This occurred in 1989 and 1990. In the Yugoslavia trial, when the placebo patients walked into the doctor's office suffering withdrawal symptoms, the SKB agents saw relapse criteria, not symptoms of withdrawal.

Here's the clever bit...

When clinical trials are set up they must have a protocol, an official procedure or system of rules. The protocol in the Yugoslavia trial was, it has to be said, genius.

Doctors were not looking for a withdrawal problem, they were, according to the protocol, looking for a relapse.

This from the legal brief...

When a patient goes to the doctor's office, scientifically validated medical procedures should be followed by the physician in order to attain an accurate diagnosis. In the case of ongoing clinical trials, however, as with the "Hamilton" suicidality indices, the physicians as well as the patients are on a pre-planned glide path in accordance with the trial protocol. Given this was a relapse study, medical ethics require the responsible clinician to abandon the trial for patient emergencies and safety, and to always follow sound medical procedures. Nevertheless, the high stakes nature of the clinical trials likely prevailed in the PI's mind. This does not necessarily suggest that the PI is intentionally cheating. What is does suggest are that test objectives taint the prism through which the PI observes patient symptoms. In the Yugoslavia trial, when the placebo patients walked into the doctor's office suffering withdrawal symptoms, the SKB agents saw relapse criteria, not symptoms of withdrawal. Alternatively, it is alleged on information and belief that many physicians in Phase II of the Yugoslavia study indeed detected and reported Paxil withdrawal symptoms for what they were. They did this in written patient summaries submitted to SKB headquarters. However, because of SKB's study design and desire to avoid the "withdrawal" issue at all costs, SKB chose to interpret the withdrawal data as "relapse" data and reported it as such to the FDA.

Here's how SKB spun the data.

  • At the six month mark in Phase II, SKB reported placebo patients suffered 450% more relapse incidents than did the Paxil patients.
  • Eighteen placebo patients suffered "relapse" while only four Paxil patients did. This published result was to show that patients staying on Paxil continued to enjoy a normal, "depression free" life, but that those abandoning the drug would suffer relapse back into a depressive state.

Coming soon, Part II where I'll be showing how SKB tried to keep a lid on the Yugoslavia trial to avoid detailed scrutiny by the FDA. They did this by manipulating (according to the legal brief) Dr. Thomas Laughren, an FDA official.




Bob Fiddaman.











Tuesday, July 07, 2015

The Seroxat Scandal - 2007





Following on from my previous posts regarding BBC TV's Panorama and their coverage of GlaxoSmithKline's Seroxat.

In 2007 they aired their 4th and final installment into the whole Seroxat scandal. 'The Secrets of the Drug Trials' focused on the infamous Paxil 329 study and showed how bosses at Glaxo knew about the suicide link with children and teenagers taking their blockbuster antidepressant - they knew yet still paid highly ranked psychiatrists to spread the word to colleagues that Seroxat was safe and effective for use in children and teenagers. Even more worrisome, GSK paid key opinion leaders huge amounts of money for writing about the benefits of Seroxat in children and teenagers, yet these same key opinion leaders didn't actually write the material - GSK hired an outside agency to ghostwrite the articles for the key opinion leaders. In essence, GSK just paid for leading psychiatrists in the field of pediatrics to add their name to the ghostwritten material and to make believe that it was their work.

The previous three Seroxat specials can be seen here, here and here.

Here's The Secrets of the Drug Trials (Starts 50 seconds in)






Bob Fiddaman.









Goodnight Channel 5






Channel Five's final say on the product placement matter, or rather my final correspondence with them.

I see no point in banging my head against a brick wall, I did it for years with the British drug regulator and don't intend to go down that road again.

In a nutshell, Channel 5 bosses see no problem with advertising...or rather placing GSK's products on popular TV shows. They see no problem, it seems, with Glaxo's admittance of guilt for various fraudulent activities nor do they see any future UK litigation pending against GSK as a problem regarding placing GSK brands in popular TV shows that they broadcast.

The two previous emails sent to me can be seen here and here.

Here's their third. My reply is below theirs. I won't be pursuing this matter any further. Channel 5 have made their position clear.

Date:  3rd July 2015


Dear Bob

Thank you for your latest e-mail.

When the products referred to were featured in the Big Brother house, no statements were made regarding them or their benefits. Channel 5 is satisfied that a product placement deal involving those products could not be interpreted as being misleading in any way. You will understand that the ASA ruling was in relation to an advertisement and not the product itself.  

Like all product placement deals, this one was fully compliant with relevant broadcasting legislation and the law.

Channel 5 will continue to make commercial arrangements with whatever corporate entities it chooses. Litigation concerning such corporate entities does not necessarily affect the appropriateness of commercial arrangements.

Yours sincerely


Ian
VIEWER ADVISOR



--

My reply.


Dear Ian,

Thank you for confirming Channel Five's position on this.

I won't be in touch again.

Sincerely


Bob Fiddaman.


---



Bob Fiddaman.











Friday, July 03, 2015

The Seroxat Scandal 2004






After the success of the first two BBC Panorama documentaries highlighting the dangers of Seroxat (Part 1, Part 2), investigative reporter/journalist, Shelley Jofre, turned the spotlight on to the people that are supposed to protect the British public from unsafe drugs, namely, the MHRA.

This third installment, Taken on Trust, highlights the total incompetence of the British drug regulator. They had previously declined to be interviewed for the first two Seroxat documentaries - judging by the performance of MHRA spokesperson, Alasdair Breckenridge (above), they are probably glad that they did. Breckenridge, incidentally, was GlaxoSmithKline's Scientific Adviser and former head of the MHRA. At the time of Taken on Trust, Breckenridge was merely steering the ship and waiting for the appointment of Kent Woods to take over as CEO of the MHRA.

I met with Woods in 2008. Ideas were discussed... then locked away. That meeting is featured in my book, The evidence, however, is clear, the Seroxat scandal (Amazon)

This third installment is groundbreaking and is a must-watch. It's embarrassing for the MHRA too.

To date, the MHRA, whose current CEO, Ian Hudson, is former World Safety Officer for GlaxoSmithKline, have sat back and shrugged their shoulders at complaints from patients who have struggled to come off Seroxat. They have offered no solution to patients being addicted to Seroxat, in fact the only solution they seem to offer is the bog-standard line that Seroxat isn't addictive and cannot cause suicide in adults, ironically it's a line used by GlaxoSmithKline too.

The MHRA are funded by the pharmaceutical industry. Make of that what you will.

Here's Taken On Trust.




Bob Fiddaman.



Thursday, July 02, 2015

The Seroxat Scandal - 2002 - 2003









I'd not long finished writing my book, it's original title, "Seroxat Sufferers", didn't sit right with me...and then it came to me, in a flash. I was laying in bed, my four-legged companion, Benn, as always, by my side. That's when I heard the voice, a voice that had, if I'm being honest, haunted me for sometime.

"The evidence, however, is clear."

There's the title of the book right there, I thought.

I jumped out of bed, fired up the computer and brought up the manuscript. I deleted the title and replaced it with, "The evidence, however, is clear, the Seroxat scandal." - A book was born and the title was a two fingered salute to the person who coined the phrase.

It's fair to say that I'm not particularly fond of the former European Medical Director of GlaxoSmithKline, Alistair Benbow, but I can, at the very least, thank him for giving me the title of my book.

You see, it was Benbow who uttered that infamous line. "The evidence, however, is clear, these medicines are not linked with suicide, these medicines are not linked with an increased rate of self harm."

He, during his 10 year tenure at GSK, became the spokesperson for Seroxat in the UK. His appearance on BBC TV's Panorama shows were, if you had experienced the addictive qualities of Seroxat, annoying to say the least.

The first Panorama documentary regarding Seroxat first aired in 2002. The Secrets of Seroxat was, in the main, about the withdrawal problem that patients were enduring, it also featured the story of Don Schell, the 60 year-old who, after taking just two Seroxat tablets (called Paxil in the US) killed his wife, Rita Schell, 55. their daughter, Deborah Tobin, 31, and Alyssa Tobin, 9 months.

The Jury in that trial blamed Seroxat as the cause of Schell's induced psychosis and subsequent slaying of his family members. Schell took his own life after killing them.

The Secrets of Seroxat hit a nerve with the British public. The feedback was unprecedented with thousands of people contacting the programme.

Many of the e-mails and phone calls sent in from Panorama viewers after the first installment said they showed signs of violence, addiction, self-harm and suicide.

If, you have not watched the first of the Panorama programmes then watching the second may be confusing.

Both of them are now available.

There were four in all. Ill be uploading the last two shortly.

Shelley Jofre is the investigative journalist and her grilling of Benbow in these first two installments is a sight to behold.

Without further ado, as they say...









Bob Fiddaman







WARNING: Pharma Payments May Give You Worms!









I now have access to the database that shows exactly how many Doctors GSK paid in 2014. I'll be writing extensively about this over the coming weeks.

In the meantime, here's a doctor who, it appears, either has some sort of binge eating disorder or has a bad case of worms.

DR. ROGER ABRAHAMS





His specialty is Allopathic & Osteopathic Physicians/Internal Medicine, Pulmonary Disease and he is based, according to the data, at 1265 Pineview Dr, Morgantown, WV 26505-2713

Here's what GSK gave him for his food and beverages.

**Note how particularly peckish Dr Abrahams was on May 3**


GlaxoSmithKline Payments
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
FOOD & BEVERAGE
1/27/2014
1/27/2014
2/25/2014
4/14/2014
4/21/2014
4/30/2014
5/2/2014
5/3/2014
5/3/2014
5/3/2014
5/3/2014
5/3/2014
5/4/2014
5/4/2014
5/4/2014
5/13/2014
6/6/2014
6/17/2014
6/17/2014
6/20/2014
7/28/2014
7/28/2014
8/11/2014
8/11/2014
8/18/2014
9/11/2014
12/2/2014
12/2/2014
12/11/2014
12/11/2014
$11.57
$1.20
$15.86
$13.05
$7.20
$23.85
$114.94
$17.73
$82.22
$60.81
$126.96
$15.71
$55.72
$49.37
$20.21
$93.40
$2.12
$1.03
$11.82
$47.85
$2.02
$9.58
$0.97
$8.56
$32.25
$13.85
$11.95
$2.85
$9.15
$0.43

And these were just payments from GSK.

Here's what AstraZeneca paid him. He, it appears, really pushed the boat out on May 5, spending a total of $372 on food and beverages. That's a fortnight's groceries to the likes of your average person.


AstraZeneca Payments
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
02/06/14
3/5/2014
3/5/2014
5/5/2014
5/5/2014
5/5/2014
5/5/2014
6/25/2014
12/18/2014
$14.99
$1.71
$14.16
$55.98
$135.00
$117.17
$63.91
$11.45
$14.67

Next we have Boehringer Ingelheim...


Boehringer Ingelheim Payments
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
1/16/2014
5/21/2014
9/16/2014
10/8/2014
10/12/2014
12/10/2014
12/10/2014
$3.72
$11.46
$12.01
$12.01
$9.03
$40.64
$9.01


The there was Forest Pharmaceuticals...


Forest Pharmaceuticals Payments
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
1/22/2014
2/10/2014
2/28/2014
3/26/2014
4/1/2014
4/7/2014
4/21/2014
5/8/2014
5/19/2014
6/9/2014
6/24/2014
7/14/2014
7/30/2014
9/5/2014
$11.72
$1.50
$9.30
$19.63
$15.97
$15.67
$1.78
$2.64
$5.60
$2.29
$1.92
$8.89
$7.28
$5.01

Just a couple of dining expenses from Genentech USA, Inc.

Food and Beverage - 7/30/2014 - $7.28 and 9/5/2014  - $5.01

Next up, Meda Pharmaceuticals, Inc.


Meda Pharmaceuticals, Inc Payments
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
1/8/2014
5/14/2014
9/24/2014
10/20/2014
12/18/2014
$13.56
$12.90
$10.65
$11.65
$101.35

One from Merck Sharp & Dohme Corporation

Food and Beverage 11/19/2014 - $15.99

Mylan Specialty L.P. are next...

Food and Beverage 7/1/2014 - $17.58 and 7/1/2014 $1.76

Other minor one offs with other pharmaceutical companies, then Teva Pharmaceuticals USA, Inc


Teva Pharmaceuticals USA, Inc Payments
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
Food and Beverage
3/20/2014
4/8/2014
5/13/2014
8/27/2014
10/9/2014
$10.35
$12.34
$15.51
$11.23
$13.54


Quite an appetite, I'm sure you'll agree.


Payments to Roger Abrahams didn't end there. He was also paid travel expenses and, as we shall see, for other miscellaneous activities.


TRAVEL & LODGING PAYMENTS

Before the integrity agreement was signed by GlaxoSmithKline in the recent $3 billion whisleblower lawsuit, Glaxo reps would often make payments for travel expenses. Blair Hamrick, who, along with others, blew the whistle on GSK, told me, "Back in the day, doctors were given the choice on one first class airfare, or could trade in for two coach tickets on these trips. They would always opt for two tickets and bring someone. After we filed they stopped doing that. " Blair also informed me that, "There was speculation that a lot of doctors would paddle their expenses, in as much as they would turn in receipts without actually buying anything, to get extra money."

On the subject of food and beverages Blair told me, "Back when we filed the case, Doctors would always bring spouses or guests. It was like a fully paid vacation. Right after the case was filed, they changed the rules to say that it was Doctors only. I don't know whether they are sticking to the rule or not these days."

This, in no way implies that Dr. Roger Abrahams was doing this. I just thought I'd give the reader some background into what Glaxo reps did and what the doctors, back then, chose to do.

Here's Dr Abraham's travel and lodging expenses.



AstraZeneca Pharmaceuticals LP
Travel and Lodging
Travel and Lodging
Travel and Lodging
Travel and Lodging
05/04/14
5/4/2014
5/5/2014
5/5/2014
$408.30
$1,115.22
$51.91
$78.71

Boehringer Ingelheim Pharmaceuticals, Inc.
Travel and Lodging
12/10/14
$1,116.70


GlaxoSmithKline
Travel and Lodging
Travel and Lodging
Travel and Lodging  
Travel and Lodging
Travel and Lodging
Travel and Lodging
3/28/2014
5/2/2014
5/2/2014
5/4/2014
5/7/2014
8/20/2014
$529.50
$335.26
$44.00
$16.43
$25.76
$44.24


CONSULTING FEES PAID BY

Boehringer Ingelheim Pharmaceuticals, Inc.

1/28/2014 $150.00
3/2/2014      $682.50
3/26/2014 $1,000.00
3/26/2014 $4,000.00

GlaxoSmithKline

8/18/2014 $300.00




As always, I've saved the best until last.

The following falls under the vague category of...

"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program."


Boehringer Ingelheim Pharmaceuticals, Inc. AND **Boehringer Ingelheim Pharma GmbH & Co.KG
Compensation
Compensation
Compensation
Compensation
Compensation
Compensation
Compensation
Compensation**
Compensation**
Compensation**
Compensation**
Compensation**
12/15/2014
12/15/2014
12/15/2014
12/15/2014
12/15/2014
12/15/2014
12/15/2014
7/7/2014
7/10/2014
9/8/2014
10/20/2014
10/30/2014
$490.00
$4,321.00
$1,212.00
$1,461.00
$490.00
$1,461.00
$490.00
$188.31
$175.00
$521.86
$1,469.93
$562.00


GlaxoSmithKline
Compensation
Compensation
Compensation
Compensation
Compensation
Compensation
05/05/14
6/4/2014
6/11/2014
6/17/2014
6/19/2014
9/15/2014
$1,300.00
$800.00
$800.00
$800.00
$1,300.00
$1,450.00


Over the coming weeks I'll be dissecting the database even more.


I'm now off for a sandwich... paid for by myself.


Bob Fiddaman.











Please contact me if you would like a guest post considered for publication on my blog.